7 drug makers fined for illicit rebates

The country’s corporate watchdog said on January 15 that it has imposed a combined 20.4 billion won in fines on seven pharmaceutical companies for unfair trading practices, including the provision of illegal rebates to hospitals and wholesalers.

The Fair Trade Commission (FTC) said GlaxoSmithKline has been fined the largest amount at 5.1 billion won, followed by Daewoong with 4.6 billion won...